Clinical Trials
11
Active:0
Completed:10
Trial Phases
3 Phases
Phase 1:1
Phase 2:3
Not Applicable:7
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Not Applicable
7 (63.6%)Phase 2
3 (27.3%)Phase 1
1 (9.1%)Dry Eye Symptom Relief Assessment With Use of TrueTear in a Controlled Adverse Environment
Not Applicable
Completed
- Conditions
- Dry Eye SyndromesDry Eye
- First Posted Date
- 2017-03-31
- Last Posted Date
- 2018-10-18
- Lead Sponsor
- Oculeve, Inc.
- Target Recruit Count
- 57
- Registration Number
- NCT03097614
- Locations
- 🇺🇸
Andover Eye Associates, Andover, Massachusetts, United States
Tear Production by Nasal Neurostimulation Compared to Active Control
Not Applicable
Completed
- Conditions
- Dry EyeKeratoconjunctivitis SiccaDry Eye Syndromes
- First Posted Date
- 2016-11-22
- Last Posted Date
- 2021-10-19
- Lead Sponsor
- Oculeve, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT02970799
Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
Not Applicable
Completed
- Conditions
- Keratoconjunctivitis SiccaDry Eye Syndrome
- First Posted Date
- 2016-06-14
- Last Posted Date
- 2017-10-25
- Lead Sponsor
- Oculeve, Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT02798289
- Locations
- 🇺🇸
Sall Research Medical Center, Artesia, California, United States
🇺🇸Aesthetic Eyecare Institute, Newport Beach, California, United States
A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye Syndrome
Not Applicable
Completed
- Conditions
- Keratoconjunctivitis SiccaDry Eye Syndrome
- First Posted Date
- 2016-02-11
- Last Posted Date
- 2019-04-26
- Lead Sponsor
- Oculeve, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT02680158
- Locations
- 🇺🇸
The Eye Care Group, Waterbury, Connecticut, United States
🇺🇸Virginia Eye Consultants, Norfolk, Virginia, United States
Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator
Not Applicable
Completed
- Conditions
- Dry Eye SyndromesKeratoconjunctivitis Sicca
- First Posted Date
- 2015-08-18
- Last Posted Date
- 2017-10-31
- Lead Sponsor
- Oculeve, Inc.
- Target Recruit Count
- 97
- Registration Number
- NCT02526290
- Locations
- 🇺🇸
Cornea & Cataract Consultants of Arizona, Phoenix, Arizona, United States
🇺🇸Andover Eye Associates, Andover, Massachusetts, United States
🇺🇸Total Eye Care, Memphis, Tennessee, United States
- Prev
- 1
- 2
- Next
News
No news found